Aripiprazole (Abilify®) IM Depot Injection
Sponsors
Otsuka Pharmaceutical Development & Commercialization, Inc.
Conditions
Schizophrenia
Phase 3
Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole
CompletedNCT01432444
Start: 2011-09-30End: 2013-12-31Updated: 2015-05-07
Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole
TerminatedNCT01509053
Start: 2012-01-31End: 2012-10-31Updated: 2015-03-04